| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211609 Novel agent for improving neurotransmission failure |
| 09/21/2006 | CA2601227A1 Mecano growth factor peptides and their use |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1701943A1 5-ht2 receptors modulators, their pharmaceutical compositions and their use for the treatment of cardiovascular and muscle diseases |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1487835B1 Amides of acetic and propionic acids |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275951C Novel benzothiazine derivatives, their preparation and use |
| 09/20/2006 | CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109176 For therapy of inflammatory diseases and conditions in humans and animals |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108857 Therapy for injured muscles |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | CA2388830C Oral solution containing galanthamine and a sweetening agent |
| 09/14/2006 | WO2006067450A3 Modulator |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/13/2006 | EP1700918A2 Activatable recombinant neurotoxins |
| 09/13/2006 | EP1699470A2 Biological active blood serum obtained by electrostimulation |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105548 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105536 Compounds |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105150 Contacting neural cells with a reagent that recognizes a determinant on a cell surface marker recognized by monoclonal antibody AC133 or 5E12; selecting cells where there is contact between reagent and determinant |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/07/2006 | US20060199841 Pharmaceutical combination for the treatment of spasticity and/or pain |
| 09/07/2006 | US20060199792 Peroxynitrite decomposition catalysts and methods of use thereof |
| 09/07/2006 | US20060198842 treating skeletal muscle atrophy with a corticotropin releasing factor 2 receptor (CRF2R) agonist such as Sauvagine, urocortin II or an antibody |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 09/06/2006 | CN1829532A Use of myostatin (GDF8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 09/06/2006 | CN1273460C Benzofuran and benzothiophene derivatives |
| 09/06/2006 | CN1273129C Therapeutic compositions (II) |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101863 For skin, muscle, ocular or gastric mucosal healing |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | US20060194854 New 2-substituted - 1,3-thiazole compounds |
| 08/31/2006 | US20060194830 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
| 08/31/2006 | CA2571982A1 Methods of modulating intracellular degradation rates of toxins |
| 08/30/2006 | EP1695959A1 Compouds and methods for the inhibition of the expression of VCAM-1 |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1421198A4 Cell-based high-throughput screening methods |
| 08/30/2006 | EP1180524B1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 08/30/2006 | EP1066042B1 Steroidal saponins for treating alzheimer's disease |
| 08/30/2006 | CN1823741A Methocarbamol dry mixing suspension |
| 08/30/2006 | CN1272030C Chinese traditional medicine for treating pain of neck, shoulder, waist and leg and preparation method thereof |
| 08/30/2006 | CN1272016C Use of ginkeo bilobwa extracts for preparing medicine for treating sarcopenia |
| 08/30/2006 | CN1271987C Health-preserving liquor with functions of making human body weightless and relaxing muscle |
| 08/29/2006 | US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 08/29/2006 | US7098188 Alkali and alkaline earth metal salts of topiramate |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088198A1 Method of producing protein by using hamster igf-1 |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189566 Muscle building agent and preventive or remedy for muscle weakening |
| 08/24/2006 | US20060188525 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 08/24/2006 | CA2598570A1 Methods for producing proteins using hamster igf-1 |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692166A1 Novel muscle growth regulator |
| 08/23/2006 | CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 08/23/2006 | CN1822845A Means for preventing and treating cellular death and their biological applications |
| 08/23/2006 | CN1821249A Crystal-free type Idi prone and its preparing method |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/17/2006 | WO2003066071A8 Formulations comprising psychotropic drugs and selenium |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183797 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060182817 Steroidal sapogenins and their derivatives for treating Alzheimer's disease |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820200A Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269483C Novel Use |
| 08/15/2006 | USRE39240 pure peptides which are highly selective for a specific human receptor; treatment of neuromuscular disorders, rapid reversible immobilization of muscles in vertebrate species; pesticide |